Company Profiles

driven by the PitchBook Platform

Antoxis

Description

Owner and operator of a per-clinical drug discovery company. The company is engaged in developing treatments which target a novel family of flavonoid compounds with anti-oxidant properties to develop treatments for neurological disorders.

2005

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$934k

Total Amount Raised

6

Investors

Description

Owner and operator of a per-clinical drug discovery company. The company is engaged in developing treatments which target a novel family of flavonoid compounds with anti-oxidant properties to develop treatments for neurological disorders.

Website:

www.antoxis.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

IMS Building Foresterhill Health and Research Complex Aberdeen AB25 2ZDScotland +44 (0)12 2443 7525
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Antoxis's full profile, request a free trial.

Antoxis Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Antoxis Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Antoxis Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Genomia FundVenture CapitalMinority000 0000000 0000
Grampian BiopartnersVenture CapitalMinority000 0000000 0000
Kapital VenturesVenture CapitalMinority000 0000000 0000
Scottish EnterpriseVenture CapitalMinority000 0000000 0000
TRI CapAngel GroupMinority000 0000000 0000
Genomia Fund Venture Capital
Grampian Biopartners Venture Capital
Kapital Ventures Venture Capital
Scottish Enterprise Venture Capital
TRI Cap Angel Group

Antoxis Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Donald McPhailCo-Founder, Chief Scientific Officer & Scientific Consultant
Leslie Patmore Ph.DDirector of Drug Development
Keith WintonBoard Observer and Company Secretary
Andrew JohnstoneFounder, Board Member & Chief Executive Officer
Donald McPhail Co-Founder, Chief Scientific Officer & Scientific Consultant
Leslie Patmore Ph.D Director of Drug Development
Keith Winton Board Observer and Company Secretary
Andrew Johnstone Founder, Board Member & Chief Executive Officer

Antoxis Board Members (5)

NameRepresentingRoleSinceContact
Info
Andrew JohnstoneSelfFounder, Board Member & Chief Executive Officer000 0000
Andrew Porter Ph.DGrampian BiopartnersCo-Founder000 0000
Douglas ThomsonSelfBoard Member000 0000
Keith WintonAntoxisBoard Observer and Company Secretary000 0000
Malcolm GilliesSelfBoard Member000 0000
Andrew Johnstone Founder, Board Member & Chief Executive Officer Self
Andrew Porter Ph.D Co-Founder Grampian Biopartners
Douglas Thomson Board Member Self
Keith Winton Board Observer and Company Secretary Antoxis
Malcolm Gillies Board Member Self
Request full access to PitchBook